VENTOLIN-HFA-喘乐宁-处方.pdf

HIGHLIGHTS OF PRESCRIBING INFORMATION VENTOLIN HFA immediately and institute alternative therapy. (5.1) These highlights do not include all the information needed to use • Need for more doses of VENTOLIN HFA than usual may be a sign of VENTOLIN HFA safely and effectively. See full prescribing information deterioration of asthma and requires reevaluation of treatment. (5.2) for VENTOLIN HFA. • VENTOLIN HFA is not a substitute for corticosteroids. (5.3) • Cardiovascular effects may occur. Use with caution in patients sensitive VENTOLIN HFA (albuterol sulfate) Inhalation Aerosol to sympathomimetic drugs and patients with cardiovascular or convulsive FOR ORAL INHALATION disorders. (5.4, 5.7) Initial U.S. Approval: 1981 • Excessive use may be fatal. Do not exceed recommended dose. (5.5) INDICATIONS AND USAGE • Immediate hypersensitivity reactions may occur. Discontinue VENTOLIN HFA is a beta2-adrenergic agonist indicated for: VENTOLIN HFA immediately. (5.6) • Treatment or prevention of bronchospasm in patients aged 4 years and • Hypokalemia and changes in blood glucose may occur. (5.7, 5.8) older with reversible obstructive airway disease. (1.1) ADVERSE REACTIONS • Prevention of exercise-induced bronchospasm in patients aged 4 years and Most common adverse reactions (incidence greater than or equal to 3%) are older. (1.2)